Business Wire

THALES

Share
Thales Awarded the 2022 Frost & Sullivan Global Software License and Entitlement Market Leadership Award

Thales, with its Sentinel Platform for License and Entitlement Management, has been awarded the Best Practices Frost & Sullivan Market Leadership Award in the global software license management market. Recognized among other companies that successfully deploy best practices, growth strategies, and strategic analytics across a value chain, Thales received the Market Leadership Award for achieving the greatest market share based on its outstanding performance, products, and services.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221214005097/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

©Thales

Frost & Sullivan’s global team of Growth Pipeline experts continually identifies and evaluates growth opportunities across multiple industries, technologies, and regions worldwide. The process involves the rigorous analysis of several nominees for each award category to determine the recipient, evaluating best practices criteria across two dimensions for each nominee. Thales was successful across several categories, including product differentiation, brand strength, growth strategy excellence, product quality, and implementation excellence.

Software licensing management (SLM) production has faced several roadblocks in its development in the current market. Software manufacturers and device makers regularly struggle to prevent access to unauthorised users while ensuring legitimate users can easily access and buy their solutions. The emergence of the COVID-19 pandemic and its aftermath, as well as high costs and lack of awarenesss, mean that despite its many benefits, SLM has not grown as exponentially as it should, especially in regions such as Asia and Latin America.

Thales is a recognized leader in the software monetization field, providing the most comprehensive platform and services for license and entitlement management and helping software-as-a-service (SaaS) companies accelerate their growth. With a team of 450 experts across more than 20 countries, including the United States, much of Europe, South Korea, China, Japan, and India, Thales solidifies its position as a leader in the software license management market.

“Thales provides the most comprehensive platform for software enforcement and hardware enforcement and is focused on solutions to help the SaaS market scale quickly,” said Mukul Krishna, Global Practice Head, Frost & Sullivan.

Thales offers a comprehensive suite of software monetization solutions, using a sophisticated entitlement management capability to address any combination of SaaS, on-premises, and device-based requirements. The company provides customers with the flexibility to create, manage, and deploy custom licenses for products across distribution channels and pricing models to meet evolving customer needs. Additionally, the company enables the tracking of customer licenses; prevents their reproduction, distribution, and unauthorized use; and protects license IP theft through encryption and anti-debugging.

With its SaaS services, application programming interfaces (APIs) and web services, Thales lowers ownership cost and the high expense of customization for an elevated customer experience. In a fiercely competitive and ever-changing market, Thales has made its way to the top with an effective growth strategy and resilience and offers optimal services at a global scale.

Thales’s software monetization solutions are available for use today. For more information, download the Frost and Sullivan Growth Opportunity Analysis 2022 report or visit: https://cpl.thalesgroup.com/software-monetization.

About Thales

Thales (Euronext Paris: HO) is a global leader in advanced technologies, investing in digital and “deep tech” innovations – connectivity, big data, artificial intelligence, cybersecurity and quantum technologies – to build a confident future crucial for the development of our societies. The Group provides its customers – businesses, organisations and governments – in the defense, aeronautics, space, transport, and digital identity and security domains with solutions, services and products that help them fulfil their critical role, consideration for the individual being the driving force behind all decisions.

Thales has 81,000 employees in 68 countries. In 2021, the Group generated sales of €16.2 billion.

PLEASE VISIT

Thales Group
Security

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221214005097/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Original “Titanic Cherub” From James Cameron’s Epic Film Heads to Auction December 9 & 1024.11.2025 21:48:00 CET | Press release

Iconic Hollywood Artifact Indelibly Linked with “Jack & Rose” Portrayed by Kate Winslet and Leonardo DiCaprio One of the most recognizable and beloved set pieces from James Cameron’s Titanic heads to auction on December 9 &10 —the original Grand Staircase Cherub, seen in multiple scenes of the 1997 blockbuster, including the pivotal moment when Jack and Rose meet in front of the First Class Dining Room and the climactic moment when the Atlantic Ocean bursts through the skylight and floods the staircase, and cherub. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251124056883/en/ The iconic “cherub” with Leonardo DiCaprio & Kate Winslet in James Cameron’s “TITANIC”. The ornate fixture—crafted for the full-scale recreation of Titanic’s Grand Staircase—was gifted by the production to Martin Biallas, CEO of SEE Global Entertainment, whose immersive exhibitions have brought the world’s most famous ship to millions of fans. It now

Access Advance Announces Major Growth in Its HEVC and VVC Patent Pools24.11.2025 16:10:00 CET | Press release

Access Advance LLC today announced significant expansions of both its HEVC Advance and VVC Advance Patent Pools during the second and third quarters of 2025, underscoring continued industry confidence in the company's balanced and transparent approach to video codec licensing. This growth follows the successful January 2025 launch of Access Advance's Video Distribution Patent ("VDP") Pool, demonstrating the company's expanding role in comprehensive video codec patent licensing solutions. Among the many highlights, Sharp Corporation joined the HEVC Advance Patent Pool as a Licensor, bringing valuable intellectual property assets to the pool's already extensive patent portfolio. Additionally, Huawei Technologies Co., Ltd., already an HEVC Advance Licensor and Licensee, expanded its collaboration with Access Advance by joining the VVC Advance Patent Pool as a Licensee. HP Inc. also expanded its license to include the VVC Advance Patent Pool after previously joining HEVC Advance in 2024, w

Microsize and Schedio Group to Acquire Lonza’s Micro-Macinazione Site in Switzerland24.11.2025 15:05:00 CET | Press release

Microsize, a leading CDMO specializing in particle size reduction and control technologies, today announced it has signed an agreement to acquire Micro-Macinazione (Mic Mac), a dedicated micronization facility in Monteggio, Switzerland, from Lonza. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251124545344/en/ The agreement represents Microsize’s second acquisition from Lonza, following the successful 2022 divestment of its Quakertown, Pennsylvania site. In this transaction, Schedio Group – a Swiss-based provider of jet mills, isolators, spray dryers, and engineering services – is investing alongside Microsize to strengthen and localize its operational base in Europe, advancing a shared vision to lead the next generation of integrated particle engineering solutions. With more than 30 years of experience, Mic Mac has served the pharmaceutical industry with proven GMP-compliant jet milling and micronization capabilities for b

Hytera to Debut S1 E at PMRExpo 202524.11.2025 14:17:00 CET | Press release

Hytera, a leading global provider of critical communications technologies and solutions, today introduced the S1 E, a business-ready, palm-sized two-way radio designed specifically for the retail sector, expanding the portfolio of S Series and providing one more option for retail users to choose for their daily operations. The S1 E will make its debut at PMRExpo, the Europe's premier trade fair for secure, mission- and business-critical communication, taking place from November 25th to 27th, 2025, at Koelnmesse in Cologne, Germany. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251124768341/en/ Hytera New Released Licence-free Analogue Business Radio S1 E Adhering to the S Series’ signature design language, the S1 E combines a stylish, modern, and minimalist aesthetic with practical functionality. Weighing under 85g, the S1 E provides all-day wearing comfort without tugging or weighing down uniforms. Key enhancements and sta

Merck Takes Patient-Directed Approach to Bring Innovation to the Treatment of Rare Neuromuscular Disorder, Generalized Myasthenia Gravis24.11.2025 14:00:00 CET | Press release

Cladribine capsules have the potential to be the first oral treatment for people living with rare, chronic autoimmune neuromuscular disorder, generalized Myasthenia GravisCladribine capsules has received Fast Track designation and Orphan Drug Designation by the US FDAMerck has established an MG patient council to provide insights on how to best meet the needs of patients in the gMG rare disease community Merck, a leading science and technology company, today announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for cladribine capsules for the treatment of the rare, chronic autoimmune neuromuscular disorder, generalized Myasthenia Gravis (gMG). In June 2023, the FDA granted Orphan Drug Designation for cladribine capsules for the treatment of gMG. In addition, the Company is actively collaborating with patient organizations and Ad Scientiam, a medical technology company, to support a patient-directed approach to the future management of gMG. If approved

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye